SCHEMBL224195

SCHEMBL224195

Fc1cc[c]c(Cl)c1F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL224656 0.79
SCHEMBL407446 0.79
SCHEMBL2347090 0.75
SCHEMBL2347896 0.75
SCHEMBL3645962 0.75
SCHEMBL23531222 0.75
SCHEMBL78405 0.72
SCHEMBL17514559 0.72
SCHEMBL10804809 0.71 PTGS2 (0.31)
SCHEMBL436848 0.70 NPC1 (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 306 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118291407-A Application of short-chain dehydrogenase and mutant thereof 沈阳药科大学 2024-07-05 CN claimed
CN-111073919-B Method for preparing (S) -2- (3, 4-difluorophenyl) oxirane 尚科生物医药(上海)有限公司 2024-06-07 CN claimed
CN-118028259-A Short-chain dehydrogenase and application thereof 河北工业大学 2024-05-14 CN claimed
CN-115109759-B Carbonyl reductase LsCR mutant, engineering bacterium and application thereof in preparation of chiral alcohol by asymmetric reduction of carbonyl compound 浙江工业大学 2024-05-03 CN claimed
CN-111763662-B Ketoreductase and application thereof in synthesis of ticagrelor intermediate 上海京新生物医药有限公司 2023-12-19 CN claimed
WO-2023239768-A1 TRICYCLIC TRIAZOLO COMPOUNDS AS DGK INHIBITORS INCYTE CORPORATION (US) 2023-12-14 WO claimed
US-20230399342-A1 TRICYCLIC TRIAZOLO COMPOUNDS AS DGK INHIBITORS INCYTE CORPORATION 2023-12-14 US claimed
CN-115011573-B Alcohol dehydrogenase mutant and application thereof 浙江大学 2023-12-12 CN claimed
EP-3901147-B1 ACYLAMINO BRIDGED HETEROCYCLIC COMPOUND, AND COMPOSITION AND APPLICATION THEREOF BEIJING SCITECH MQ PHARMACEUTICALS LTD (CN) 2023-11-22 EP claimed
CN-116970580-A Short-chain dehydrogenase mutant derived from Raffina and application of short-chain dehydrogenase mutant in catalyzing aryl ketone to prepare chiral alcohol 浙江工业大学 2023-10-31 CN claimed
EP-2029614-B1 COLD MENTHOL RECEPTOR-1 ANTAGONISTS JANSSEN PHARMACEUTICA NV (BE) 2013-01-23 EP claimed
US-20110003808-A1 OCTAHYDROQUINOLIZINES FOR ANTIDIABETIC TREATMENT 55PHARMA DRUG DISCOVERY & DEVELOPMENT AG (AT) 2011-01-06 US claimed
EP-2222673-A1 OCTAHYDROQUINOLI ZINES FOR ANTIDIABETIC TREATMENT 55pharma Drug Discovery & Development AG (AT) 2010-09-01 EP claimed
US-7741479-B2 Urea inhibitors of MAP kinases LOCUS PHARMACEUTICALS, INC. (US) 2010-06-22 US claimed
WO-2009076693-A1 OCTAHYDROQUINOLI ZINES FOR ANTIDIABETIC TREATMENT 55PHARMA DRUG DISCOVERY & DEVELOPMENT AG (AT) 2009-06-25 WO claimed
WO-2007135527-A2 BENZIMIDAZOLYL COMPOUNDS PFIZER PRODUCTS INC. (US) 2007-11-29 WO claimed
WO-2007135529-A2 AZABENZIMIDAZOLYL COMPOUNDS AS MGLUR2 POTENTIATORS PFIZER PRODUCTS INC. (US) 2007-11-29 WO claimed
EP-1828169-A2 UREA INHIBITORS OF MAP KINASES Locus Pharmaceuticals, Inc. (US) 2007-09-05 EP claimed
US-20060167247-A1 Urea inhibitors of MAP kinases LOCUS PHARMACEUTICALS, INC. 2006-07-27 US claimed
WO-2006062982-A2 UREA INHIBITORS OF MAP KINASES LOCUS PHARMACEUTICALS, INC. (US) 2006-06-15 WO claimed